ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $28,064 | +22.0% | 75,643 | +64.6% | 0.00% | – |
Q3 2022 | $23,000 | -78.3% | 45,953 | -43.0% | 0.00% | – |
Q4 2021 | $106,000 | +265.5% | 80,648 | +540.2% | 0.00% | – |
Q3 2021 | $29,000 | -63.3% | 12,597 | +15.2% | 0.00% | – |
Q1 2021 | $79,000 | +71.7% | 10,934 | +3.4% | 0.00% | – |
Q4 2020 | $46,000 | – | 10,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 6,449,856 | $8,514,000 | 2.83% |
RA Capital Management | 9,694,789 | $12,797,000 | 0.23% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $9,173,000 | 0.19% |
HARBOR CAPITAL ADVISORS, INC. | 275,870 | $364,000 | 0.13% |
Artal Group S.A. | 1,803,858 | $2,381,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 338,756 | $447,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,335,174 | $1,762,000 | 0.05% |
PVG ASSET MANAGEMENT CORP | 10,000 | $13,200,000 | 0.05% |
Anson Funds Management LP | 348,266 | $460,000 | 0.04% |
Eversept Partners, LP | 419,581 | $553,847 | 0.04% |